Cargando…
Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway
Both neutralization and antibody-dependent cellular cytotoxicity (ADCC) may be required for effective protection against HIV-1 infection. While there is extensive information on the targets of early neutralizing antibody (nAb) responses, much less is known about the targets of ADCC responses, which...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6919271/ https://www.ncbi.nlm.nih.gov/pubmed/31921139 http://dx.doi.org/10.3389/fimmu.2019.02875 |
_version_ | 1783480736380092416 |
---|---|
author | Mielke, Dieter Bandawe, Gama Pollara, Justin Abrahams, Melissa-Rose Nyanhete, Tinashe Moore, Penny L. Thebus, Ruwayhida Yates, Nicole L. Kappes, John C. Ochsenbauer, Christina Garrett, Nigel Abdool Karim, Salim Tomaras, Georgia D. Montefiori, David Morris, Lynn Ferrari, Guido Williamson, Carolyn |
author_facet | Mielke, Dieter Bandawe, Gama Pollara, Justin Abrahams, Melissa-Rose Nyanhete, Tinashe Moore, Penny L. Thebus, Ruwayhida Yates, Nicole L. Kappes, John C. Ochsenbauer, Christina Garrett, Nigel Abdool Karim, Salim Tomaras, Georgia D. Montefiori, David Morris, Lynn Ferrari, Guido Williamson, Carolyn |
author_sort | Mielke, Dieter |
collection | PubMed |
description | Both neutralization and antibody-dependent cellular cytotoxicity (ADCC) may be required for effective protection against HIV-1 infection. While there is extensive information on the targets of early neutralizing antibody (nAb) responses, much less is known about the targets of ADCC responses, which are more difficult to characterize. In four individuals recruited during acute HIV-infection, ADCC responses were detected 3–7 weeks prior to nAb responses. To determine the relative influence of ADCC and nAb responses on virus evolution, we performed an in-depth investigation of one individual (CAP63) who showed the highest nAb and ADCC responses. Both nAbs and ADCC antibodies targeted the V4 region of the Env, although there were some differences in epitope recognition. We identified accelerated viral evolution in this region concurrent with emergence of nAb activity, but not ADCC activity. Deep sequencing demonstrated that most nAb escape mutations were strongly selected for, however one nAb escape mutation that rendered the virus highly susceptible to autologous ADCC responses, was suppressed despite not affecting viral fitness. This escape mutation also rendered the virus more sensitive to autologous responses, as well as monoclonal antibodies targeting CD4-induced epitopes, compared to the wildtype virus. In conclusion, ADCC responses and nAbs in donor CAP63 recognized overlapping but unique epitopes in the V4 region, and while ADCC activity was present prior to nAbs, it did not drive viral evolution during this time. However, ADCC responses may select against nAb escape pathways that expose other common ADCC epitopes thereby restricting viral replication and expansion. |
format | Online Article Text |
id | pubmed-6919271 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-69192712020-01-09 Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway Mielke, Dieter Bandawe, Gama Pollara, Justin Abrahams, Melissa-Rose Nyanhete, Tinashe Moore, Penny L. Thebus, Ruwayhida Yates, Nicole L. Kappes, John C. Ochsenbauer, Christina Garrett, Nigel Abdool Karim, Salim Tomaras, Georgia D. Montefiori, David Morris, Lynn Ferrari, Guido Williamson, Carolyn Front Immunol Immunology Both neutralization and antibody-dependent cellular cytotoxicity (ADCC) may be required for effective protection against HIV-1 infection. While there is extensive information on the targets of early neutralizing antibody (nAb) responses, much less is known about the targets of ADCC responses, which are more difficult to characterize. In four individuals recruited during acute HIV-infection, ADCC responses were detected 3–7 weeks prior to nAb responses. To determine the relative influence of ADCC and nAb responses on virus evolution, we performed an in-depth investigation of one individual (CAP63) who showed the highest nAb and ADCC responses. Both nAbs and ADCC antibodies targeted the V4 region of the Env, although there were some differences in epitope recognition. We identified accelerated viral evolution in this region concurrent with emergence of nAb activity, but not ADCC activity. Deep sequencing demonstrated that most nAb escape mutations were strongly selected for, however one nAb escape mutation that rendered the virus highly susceptible to autologous ADCC responses, was suppressed despite not affecting viral fitness. This escape mutation also rendered the virus more sensitive to autologous responses, as well as monoclonal antibodies targeting CD4-induced epitopes, compared to the wildtype virus. In conclusion, ADCC responses and nAbs in donor CAP63 recognized overlapping but unique epitopes in the V4 region, and while ADCC activity was present prior to nAbs, it did not drive viral evolution during this time. However, ADCC responses may select against nAb escape pathways that expose other common ADCC epitopes thereby restricting viral replication and expansion. Frontiers Media S.A. 2019-12-11 /pmc/articles/PMC6919271/ /pubmed/31921139 http://dx.doi.org/10.3389/fimmu.2019.02875 Text en Copyright © 2019 Mielke, Bandawe, Pollara, Abrahams, Nyanhete, Moore, Thebus, Yates, Kappes, Ochsenbauer, Garrett, Abdool Karim, Tomaras, Montefiori, Morris, Ferrari and Williamson. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Mielke, Dieter Bandawe, Gama Pollara, Justin Abrahams, Melissa-Rose Nyanhete, Tinashe Moore, Penny L. Thebus, Ruwayhida Yates, Nicole L. Kappes, John C. Ochsenbauer, Christina Garrett, Nigel Abdool Karim, Salim Tomaras, Georgia D. Montefiori, David Morris, Lynn Ferrari, Guido Williamson, Carolyn Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway |
title | Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway |
title_full | Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway |
title_fullStr | Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway |
title_full_unstemmed | Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway |
title_short | Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway |
title_sort | antibody-dependent cellular cytotoxicity (adcc)-mediating antibodies constrain neutralizing antibody escape pathway |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6919271/ https://www.ncbi.nlm.nih.gov/pubmed/31921139 http://dx.doi.org/10.3389/fimmu.2019.02875 |
work_keys_str_mv | AT mielkedieter antibodydependentcellularcytotoxicityadccmediatingantibodiesconstrainneutralizingantibodyescapepathway AT bandawegama antibodydependentcellularcytotoxicityadccmediatingantibodiesconstrainneutralizingantibodyescapepathway AT pollarajustin antibodydependentcellularcytotoxicityadccmediatingantibodiesconstrainneutralizingantibodyescapepathway AT abrahamsmelissarose antibodydependentcellularcytotoxicityadccmediatingantibodiesconstrainneutralizingantibodyescapepathway AT nyanhetetinashe antibodydependentcellularcytotoxicityadccmediatingantibodiesconstrainneutralizingantibodyescapepathway AT moorepennyl antibodydependentcellularcytotoxicityadccmediatingantibodiesconstrainneutralizingantibodyescapepathway AT thebusruwayhida antibodydependentcellularcytotoxicityadccmediatingantibodiesconstrainneutralizingantibodyescapepathway AT yatesnicolel antibodydependentcellularcytotoxicityadccmediatingantibodiesconstrainneutralizingantibodyescapepathway AT kappesjohnc antibodydependentcellularcytotoxicityadccmediatingantibodiesconstrainneutralizingantibodyescapepathway AT ochsenbauerchristina antibodydependentcellularcytotoxicityadccmediatingantibodiesconstrainneutralizingantibodyescapepathway AT garrettnigel antibodydependentcellularcytotoxicityadccmediatingantibodiesconstrainneutralizingantibodyescapepathway AT abdoolkarimsalim antibodydependentcellularcytotoxicityadccmediatingantibodiesconstrainneutralizingantibodyescapepathway AT tomarasgeorgiad antibodydependentcellularcytotoxicityadccmediatingantibodiesconstrainneutralizingantibodyescapepathway AT montefioridavid antibodydependentcellularcytotoxicityadccmediatingantibodiesconstrainneutralizingantibodyescapepathway AT morrislynn antibodydependentcellularcytotoxicityadccmediatingantibodiesconstrainneutralizingantibodyescapepathway AT ferrariguido antibodydependentcellularcytotoxicityadccmediatingantibodiesconstrainneutralizingantibodyescapepathway AT williamsoncarolyn antibodydependentcellularcytotoxicityadccmediatingantibodiesconstrainneutralizingantibodyescapepathway |